ENTITY

Cingulate (CING US)

7
Analysis
Health Care • United States
Cingulate Inc. operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
more
Exchange Announcement • 13 Nov 2025 21:15
Exchange Announcement • 13 Nov 2025 08:00
Exchange Announcement • 10 Nov 2025 21:17
Exchange Announcement • 14 Oct 2025 20:15
Exchange Announcement • 26 Sep 2025 05:00
x